Eaton Vance Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Eaton Vance Management's HALO Position: Q3 2022 in Review
Eaton Vance Management reduced its Halozyme (HALO) stake by 0.04% in Q3 2022, selling an estimated $2.52K and leaving 139,396 shares worth $5.51M. The position accounts for 0.01% of the portfolio, ranked #749.
Eaton Vance Management first reported a position in HALO in Q1 2018 and has held it in 19 quarters since. The position peaked at $6.14M in Q2 2022. 357 funds tracked by Wall St. Rank hold HALO as of Q3 2022.
- Eaton Vance Management held 139,396 shares of Halozyme worth $5.51M as of Q3 2022.
- Eaton Vance Management sold 57 Halozyme shares in Q3 2022, an estimated $2.52K.
- Halozyme made up 0.01% of Eaton Vance Management's portfolio in Q3 2022, its #749 holding.
- Eaton Vance Management first reported a position in Halozyme in Q1 2018 and has held it in 19 quarters since.
- Eaton Vance Management's Halozyme position peaked at $6.14M in Q2 2022.
- 357 funds tracked by Wall St. Rank held Halozyme as of Q3 2022.
Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.